ERSOT
CLVS

Employees Retirement System of Texas’s Clovis Oncology, Inc. CLVS Stock Holding History

Employees Retirement System of Texas’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,000
Closed -$700K – 1050
2017
Q1 		$700K Buy
+11,000
New +$669K 0.01% 911

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Employees Retirement System of Texas's CLVS Position: Q2 2017 in Review

Employees Retirement System of Texas sold out of Clovis Oncology, Inc. (CLVS) in Q2 2017, closing a stake of 11,000 shares — an estimated $700K sold.

Employees Retirement System of Texas first reported a position in CLVS in Q1 2017 and held it in 1 quarter. The position peaked at $700K in Q1 2017. 271 funds tracked by Wall St. Rank hold CLVS as of Q2 2017.

  • Employees Retirement System of Texas reported no remaining Clovis Oncology, Inc. position as of Q2 2017 after selling out during the quarter.
  • Employees Retirement System of Texas sold 11,000 Clovis Oncology, Inc. shares in Q2 2017, an estimated $700K.
  • Employees Retirement System of Texas first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 1 quarter.
  • Employees Retirement System of Texas's Clovis Oncology, Inc. position peaked at $700K in Q1 2017.
  • 271 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2017.

Based on Employees Retirement System of Texas's 13F filing for Q2 2017, filed 14 Aug 2017.